Cystic Fibrosis Therapeutics Market 2027 By Drugs, Route of Administration | The Insight Partners

Cystic Fibrosis Therapeutics Market to 2027 - Global Analysis and Forecasts by Drugs (Pancreatic enzyme supplements, Mucolytic, Bronchodilators, CFTR Modulators); Route of Administration (Oral, Injectable)

Report Code: TIPRE00004607 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Cystic Fibrosis also known as mucoviscidosis is a genetic disorder characterized by abnormal transport of chloride and sodium across an epithelium, resulting results in lung infection that curbs the ability to breathe.

MARKET DYNAMICS
The Cystic Fibrosis Therapeutics market is anticipated to grow in the forecast period owing to driving factors such as growing prevalence of cystic fibrosis, increasing awareness, strong pipeline candidates, technological advancements and growing R&D initiatives. Nevertheless, the high cost of treatment and increasing complexity of disease is expected to restrict the market growth during the forecast period.

MARKET SCOPE
The "Global Cystic Fibrosis Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Cystic Fibrosis Therapeutics market with detailed market segmentation by Drug, Route of Administration and geography. The global Cystic Fibrosis Therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Cystic Fibrosis Therapeutics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Cystic Fibrosis Therapeutics market is segmented on the basis of Drugs and Route of Administration. Based on Drugs the market is segmented into Pancreatic enzyme supplements, Mucolytic, Bronchodilators, CFTR Modulators. Based on route of administration the market is segmented into Oral, Injectable.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Cystic Fibrosis Therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Cystic Fibrosis Therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Cystic Fibrosis Therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Cystic Fibrosis Therapeutics market in these regions.

MARKET PLAYERS
The reports cover key developments in the Cystic Fibrosis Therapeutics Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Cystic Fibrosis Therapeutics Market are anticipated to lucrative growth opportunities in the future with the rising demand for Cystic Fibrosis Therapeutics in the global market. Below mentioned is the list of few companies engaged in the Cystic Fibrosis Therapeutics market.

The report also includes the profiles of key Cystic Fibrosis Therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • AbbVie
  • Allergan plc
  • Genentech, Inc.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline
  • Johnson & Johnson
  • Mylan N.V
  • Novartis
  • Pharmaxis Ltd
  • Vertex Pharmaceuticals Incorporated
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cystic Fibrosis Therapeutics Market - By Drugs
1.3.2 Cystic Fibrosis Therapeutics Market - By Route of Administration
1.3.3 Cystic Fibrosis Therapeutics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CYSTIC FIBROSIS THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CYSTIC FIBROSIS THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CYSTIC FIBROSIS THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. CYSTIC FIBROSIS THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. CYSTIC FIBROSIS THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CYSTIC FIBROSIS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DRUGS
7.1. OVERVIEW
7.2. DRUGS MARKET FORECASTS AND ANALYSIS
7.3. PANCREATIC ENZYME SUPPLEMENTS
7.3.1. Overview
7.3.2. Pancreatic enzyme supplements Market Forecast and Analysis
7.4. MUCOLYTIC
7.4.1. Overview
7.4.2. Mucolytic Market Forecast and Analysis
7.5. BRONCHODILATORS
7.5.1. Overview
7.5.2. Bronchodilators Market Forecast and Analysis
7.6. CFTR MODULATORS
7.6.1. Overview
7.6.2. CFTR Modulators Market Forecast and Analysis
8. CYSTIC FIBROSIS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. INJECTABLE
8.4.1. Overview
8.4.2. Injectable Market Forecast and Analysis
9. CYSTIC FIBROSIS THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Cystic Fibrosis Therapeutics Market Overview
9.1.2 North America Cystic Fibrosis Therapeutics Market Forecasts and Analysis
9.1.3 North America Cystic Fibrosis Therapeutics Market Forecasts and Analysis - By Drugs
9.1.4 North America Cystic Fibrosis Therapeutics Market Forecasts and Analysis - By Route of Administration
9.1.5 North America Cystic Fibrosis Therapeutics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Cystic Fibrosis Therapeutics Market
9.1.5.1.1 United States Cystic Fibrosis Therapeutics Market by Drugs
9.1.5.1.2 United States Cystic Fibrosis Therapeutics Market by Route of Administration
9.1.5.2 Canada Cystic Fibrosis Therapeutics Market
9.1.5.2.1 Canada Cystic Fibrosis Therapeutics Market by Drugs
9.1.5.2.2 Canada Cystic Fibrosis Therapeutics Market by Route of Administration
9.1.5.3 Mexico Cystic Fibrosis Therapeutics Market
9.1.5.3.1 Mexico Cystic Fibrosis Therapeutics Market by Drugs
9.1.5.3.2 Mexico Cystic Fibrosis Therapeutics Market by Route of Administration
9.1.5.4 US Cystic Fibrosis Therapeutics Market
9.1.5.4.1 US Cystic Fibrosis Therapeutics Market by Drugs
9.1.5.4.2 US Cystic Fibrosis Therapeutics Market by Route of Administration
9.2. EUROPE
9.2.1 Europe Cystic Fibrosis Therapeutics Market Overview
9.2.2 Europe Cystic Fibrosis Therapeutics Market Forecasts and Analysis
9.2.3 Europe Cystic Fibrosis Therapeutics Market Forecasts and Analysis - By Drugs
9.2.4 Europe Cystic Fibrosis Therapeutics Market Forecasts and Analysis - By Route of Administration
9.2.5 Europe Cystic Fibrosis Therapeutics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Cystic Fibrosis Therapeutics Market
9.2.5.1.1 Germany Cystic Fibrosis Therapeutics Market by Drugs
9.2.5.1.2 Germany Cystic Fibrosis Therapeutics Market by Route of Administration
9.2.5.2 France Cystic Fibrosis Therapeutics Market
9.2.5.2.1 France Cystic Fibrosis Therapeutics Market by Drugs
9.2.5.2.2 France Cystic Fibrosis Therapeutics Market by Route of Administration
9.2.5.3 Italy Cystic Fibrosis Therapeutics Market
9.2.5.3.1 Italy Cystic Fibrosis Therapeutics Market by Drugs
9.2.5.3.2 Italy Cystic Fibrosis Therapeutics Market by Route of Administration
9.2.5.4 Spain Cystic Fibrosis Therapeutics Market
9.2.5.4.1 Spain Cystic Fibrosis Therapeutics Market by Drugs
9.2.5.4.2 Spain Cystic Fibrosis Therapeutics Market by Route of Administration
9.2.5.5 United Kingdom Cystic Fibrosis Therapeutics Market
9.2.5.5.1 United Kingdom Cystic Fibrosis Therapeutics Market by Drugs
9.2.5.5.2 United Kingdom Cystic Fibrosis Therapeutics Market by Route of Administration
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Cystic Fibrosis Therapeutics Market Overview
9.3.2 Asia-Pacific Cystic Fibrosis Therapeutics Market Forecasts and Analysis
9.3.3 Asia-Pacific Cystic Fibrosis Therapeutics Market Forecasts and Analysis - By Drugs
9.3.4 Asia-Pacific Cystic Fibrosis Therapeutics Market Forecasts and Analysis - By Route of Administration
9.3.5 Asia-Pacific Cystic Fibrosis Therapeutics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Cystic Fibrosis Therapeutics Market
9.3.5.1.1 Australia Cystic Fibrosis Therapeutics Market by Drugs
9.3.5.1.2 Australia Cystic Fibrosis Therapeutics Market by Route of Administration
9.3.5.2 China Cystic Fibrosis Therapeutics Market
9.3.5.2.1 China Cystic Fibrosis Therapeutics Market by Drugs
9.3.5.2.2 China Cystic Fibrosis Therapeutics Market by Route of Administration
9.3.5.3 India Cystic Fibrosis Therapeutics Market
9.3.5.3.1 India Cystic Fibrosis Therapeutics Market by Drugs
9.3.5.3.2 India Cystic Fibrosis Therapeutics Market by Route of Administration
9.3.5.4 Japan Cystic Fibrosis Therapeutics Market
9.3.5.4.1 Japan Cystic Fibrosis Therapeutics Market by Drugs
9.3.5.4.2 Japan Cystic Fibrosis Therapeutics Market by Route of Administration
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Cystic Fibrosis Therapeutics Market Overview
9.4.2 Middle East and Africa Cystic Fibrosis Therapeutics Market Forecasts and Analysis
9.4.3 Middle East and Africa Cystic Fibrosis Therapeutics Market Forecasts and Analysis - By Drugs
9.4.4 Middle East and Africa Cystic Fibrosis Therapeutics Market Forecasts and Analysis - By Route of Administration
9.4.5 Middle East and Africa Cystic Fibrosis Therapeutics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Cystic Fibrosis Therapeutics Market
9.4.5.1.1 South Africa Cystic Fibrosis Therapeutics Market by Drugs
9.4.5.1.2 South Africa Cystic Fibrosis Therapeutics Market by Route of Administration
9.4.5.2 Saudi Arabia Cystic Fibrosis Therapeutics Market
9.4.5.2.1 Saudi Arabia Cystic Fibrosis Therapeutics Market by Drugs
9.4.5.2.2 Saudi Arabia Cystic Fibrosis Therapeutics Market by Route of Administration
9.4.5.3 U.A.E Cystic Fibrosis Therapeutics Market
9.4.5.3.1 U.A.E Cystic Fibrosis Therapeutics Market by Drugs
9.4.5.3.2 U.A.E Cystic Fibrosis Therapeutics Market by Route of Administration
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Cystic Fibrosis Therapeutics Market Overview
9.5.2 South and Central America Cystic Fibrosis Therapeutics Market Forecasts and Analysis
9.5.3 South and Central America Cystic Fibrosis Therapeutics Market Forecasts and Analysis - By Drugs
9.5.4 South and Central America Cystic Fibrosis Therapeutics Market Forecasts and Analysis - By Route of Administration
9.5.5 South and Central America Cystic Fibrosis Therapeutics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Cystic Fibrosis Therapeutics Market
9.5.5.1.1 Brazil Cystic Fibrosis Therapeutics Market by Drugs
9.5.5.1.2 Brazil Cystic Fibrosis Therapeutics Market by Route of Administration
9.5.5.2 Argentina Cystic Fibrosis Therapeutics Market
9.5.5.2.1 Argentina Cystic Fibrosis Therapeutics Market by Drugs
9.5.5.2.2 Argentina Cystic Fibrosis Therapeutics Market by Route of Administration
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. CYSTIC FIBROSIS THERAPEUTICS MARKET, KEY COMPANY PROFILES
11.1. ABBVIE
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ALLERGAN PLC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. GENENTECH, INC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GILEAD SCIENCES, INC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GLAXOSMITHKLINE
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. JOHNSON AND JOHNSON
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MYLAN N.V
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. NOVARTIS
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. PHARMAXIS LTD
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. VERTEX PHARMACEUTICALS INCORPORATED
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

- AbbVie
- Allergan plc
- Genentech, Inc.
- Gilead Sciences, Inc.
- GlaxoSmithKline
- Johnson & Johnson
- Mylan N. V
- Novartis
- Pharmaxis Ltd
- Vertex Pharmaceuticals Incorporated